Workflow
健康160通过港交所聆讯 平台平均月活跃用户330万名
Zhi Tong Cai Jing·2025-09-04 22:59

Core Viewpoint - Health 160 International Limited is preparing for its listing on the Hong Kong Stock Exchange, with Shenwan Hongyuan and Qianhai Capital as joint sponsors [1] Company Overview - Health 160 is an experienced Chinese wholesaler of pharmaceutical health products and a leading provider of integrated digital healthcare services, offering a range of health products and comprehensive digital health solutions [3] - The company operates an online healthcare service platform, Health 160, which connects various stakeholders in the healthcare industry, including corporate clients, healthcare institutions, medical personnel, and individual users, facilitating the digital transformation of China's healthcare sector [3][4] Digital Healthcare Solutions - The Health 160 platform integrates online and offline healthcare services, connecting healthcare institutions, medical personnel, and individual users, and offers diverse medical services, including serious and consumer healthcare [4] - The company has developed effective monetization strategies for its digital healthcare solutions, generating significant revenue from various platform participants, making it a major player in China's digital healthcare service industry [4] Platform Metrics - As of March 31, 2025, the platform has connected over 44,600 healthcare institutions, including more than 14,400 hospitals (3,430 of which are tertiary hospitals) and over 30,200 grassroots healthcare institutions [4] - The company has established partnerships with over 902,300 medical personnel, including approximately 46,200 registered doctors, and has a registered user base of 55.2 million, with an average of 3.3 million monthly active users [6] Financial Performance - The company's revenue for the years ending December 31 for 2022, 2023, and 2024 was approximately RMB 526 million, RMB 629 million, and RMB 621 million, respectively, with a loss of RMB 120 million, RMB 106 million, and RMB 108 million for the same periods [6][7] - For the three months ending March 31, 2025, the company reported revenue of approximately RMB 100 million and a loss of RMB 17 million [6][7]